News and Announcements
$2.6B Market Breakthrough in Cardiac Technology | EBR Systems
- Published January 29, 2025 1:02AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join the conversation with Andrew Shute, SVP of EBR Systems, as we explore the innovative VICRD system, a leadless device poised to transform cardiac resynchronization therapy. Discover its advantages over traditional therapies, a $3.6 billion market potential, and promising clinical outcomes. Learn about EBR Systems’ U.S. expansion strategy, their pioneering rechargeable battery technology, and key milestones ahead. This episode delves into an innovation that not only advances medical technology but also offers new hope for heart failure patients.
Executive Interviews
Navigating the Market Inflection Point: Exclusive Investor & Founder Meetups Across Australia
The market is at a genuine inflection point in mid-2025, with conflicting signals from AI breakthroughs and geopolitical shifts. This blog announces exclusive, intimate investor and founder meetups across Australia, designed to cut through the noise, reveal unfiltered truths about the H2 2025 outlook, and map the “smart money migration” to position participants for strategic advantage.
Bridging the Gap: Why Australian Capital is Crucial for India’s Trillion-Dollar Growth Story
Australia’s substantial savings pool is meeting India’s explosive growth. Learn how Creek Partners is building the crucial bridge for investors seeking to tap into India’s projected $7 trillion economy and its vibrant venture capital ecosystem.
Beyond the Hype: Strategic Digital Asset Investing for a New Financial Era
The financial world is undergoing a profound transformation driven by Digital Assets. Learn why hundreds of billions are pouring into new digital infrastructure, with stablecoins now outperforming Mastercard/Visa in transaction volume. This article guides investors beyond the hype to strategic digital asset investing, exploring yield, DePIN, DeFi, and AI+Blockchain for the new financial era. Discover more at Venture & Capital SYDNEY 2025.
Backed By Leading Investment Groups and Family Offices
